/

/

Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial - Wellbeing...

Wed, Nov 30

Perspectives

Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial $KONEF $NMLSF https://t.co/PYwPQpj9Rs via @Benzinga

0

Psychedelics biotechs Nova Mentis Life Science Corp. (OTCQB: NMLSF) and Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Sciences Inc.

Discover